Page last updated: 2024-10-27

flecainide and Lupus Erythematosus, Systemic

flecainide has been researched along with Lupus Erythematosus, Systemic in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guischer, N1
Houssiau, FA1
Lhommel, R1
Coche, E1
Roelants, V1

Other Studies

1 other study available for flecainide and Lupus Erythematosus, Systemic

ArticleYear
Drug-induced lupus erythematosus mimicking lymphoma on
    Lupus, 2017, Volume: 26, Issue:8

    Topics: Aged; Autoantibodies; Diagnosis, Differential; Flecainide; Fluorodeoxyglucose F18; Glucocorticoids;

2017